Home » China Regenerative Medicine (08158) released its first nine-month net profit of HK$10.555 million, a year-on-year decrease of 46.51% | China Regenerative Medicine_Sina Finance_Sina.com

China Regenerative Medicine (08158) released its first nine-month net profit of HK$10.555 million, a year-on-year decrease of 46.51% | China Regenerative Medicine_Sina Finance_Sina.com

by admin
China Regenerative Medicine (08158) released its first nine-month net profit of HK$10.555 million, a year-on-year decrease of 46.51% | China Regenerative Medicine_Sina Finance_Sina.com

On Double Eleven, other people chop your hands and you make money, and Feitian Maotai is waiting for you! There are also seven investment tools with limited-time low-cost discounts, not to be missed.[点击进入活动页面]

Regenerative medicine in China(08158) released its results for the first nine months of 2022. Income from continuing operations was approximately HK$163 million, a year-on-year decrease of 18.4%; net profit was HK$10.555 million, a year-on-year decrease of 46.51%; earnings per share were 0.37 HK cents.

According to the announcement, the overall decrease in revenue was mainly due to the implementation of strict prevention and control of COVID-19 quarantine measures in Mainland China and Hong Kong during the period.

Open a stock account to enjoy benefits, deposit 188 yuan in red envelopes, 100% winning!

Massive information, accurate interpretation, all in Sina Finance APP

See also  Sanremo? No, Sanscemo Festival. Megalomaniacal management of Amadeus

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy